Company
Loreal USA
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
4
4 still marketed
Novel approvals
1
Approvals since 2021
0
Originals and new uses
Phase 3 trials
2
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Anthelios 40 new use Oct 29, 2009
- Anthelios 40 approved Mar 31, 2008
- Anthelios 20 approved Oct 5, 2006
- Capital Soleil 15 approved Oct 2, 2006
- Anthelios Sx approved NovelJul 21, 2006
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (4)
Newest FDA action first.
- Capital Soleil 15 Avobenzone, Ecamsule, Octocrylene · 2006
- Anthelios 40 Avobenzone, Ecamsule, Octocrylene, Titanium Dioxide · 2008
- Anthelios 20 Avobenzone, Ecamsule, Octocrylene, Titanium Dioxide · 2006
- Anthelios Sx Avobenzone, Ecamsule, Octocrylene · 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.